AcroViz
PrivateLast Round
Accelerator
Apr 21, 2022
Company Overview
AcroViz is a health care company that develops imaging biomarkers designed to analyze brain health using neural fiber imaging and machine learning to predict the risk and prognosis of dementia.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AcroViz Comparables
Compare AcroViz with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Darmiyan | 82% | |
| DeepRad AI | 80% | |
| NeuroAge Therapeutics | 78% | |
AcroViz Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 21, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 86% MoM, reaching 6.4K.
- Jan 2, 2026
Monthly visitors increased 35% MoM, from 4.8K to 6.5K.
AcroViz Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AcroViz's valuation, stock price, and market status.